Zydus Therapeutics is a clinical stage, specialty-focused bio-pharmaceutical company focused on developing transformative treatments for rare and serious liver diseases.

Zydus Therapeutics

Zydus Therapeutics | 550 followers on LinkedIn. Zydus Therapeutics is a clinical stage, bio-pharmaceutical company focused on developing treatments to transform lives. | Dedicated To Life
Zydus Therapeutics is a clinical stage, specialty-focused bio-pharmaceutical company focused on developing transformative treatments to transform lives, starting with rare and serious liver diseases and anemias.

Our Purpose Is Simple
To empower people with the freedom to live healthier and more fulfilling lives, by unlocking new possibilities in life sciences and providing quality healthcare solutions.

Chief Operating Officer at Zydus Therapeutics

Chris Cann

Research Scientist in Biomedical Research with Experience in Medical/Scientific Writing (Publications)/Medical Communications/Medical Affairs

Dr. Rajgopal Yadavalli, Ph.D

Vice President- IP at Zydus Therapeutics

Kishor Vinchhi

Senior Project Manager

Siddharth Aras

#Zydus Therapeutics is hiring a Financial Analyst https://lnkd.in/e6k87TzY

#Zydus Therapeutics is hiring a Clinical Operations Manager: https://lnkd.in/eDWJCk8x

Zydus Therapeutics is hiring a Clinical Project Manager https://lnkd.in/eHRFF6yX ; # Zydusjobs

Happy Holidays to all of our business partners, colleagues, friends and family. Stay safe and well. Zydus Therapeutics.

Metric
Company Name	Zydus Therapeutics
Symbol
MSH ID	COM:ZYDUSTX
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	IN
Stage
Employee Count
Website	zydustx.com
LinkedIn	zydus-therapeutics-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ZYDU

COM:ZYDUSTX

Zydus Therapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue